> Also, the whole point is that these people are not guinea pigs. They are allowed access to promising therapies in late stage clinical trials in the hopes that

> Also, the whole point is that these people are not guinea pigs. They are allowed access to promising therapies in late stage clinical trials in the hopes that they will help them, not just random investigational compounds I'm not positive, but I think this only requires drugs to have passed Phase I clinical trials. And that, according to the article, NurOwn's Phase II trials showed it was unable to slow the progression of ALS compared to a placebo.